Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
Holding ACUR?
Track your performance easily
ACUR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.03
Previous Close$0.02
Volume37.90K
Average Volume (3M)N/A
Market Cap
$145.20K
Enterprise Value$130.20K
Total Cash (Recent Filing)$65.00K
Total Debt (Recent Filing)$50.00K
Price to Earnings (P/E)―
Beta-0.59
Next Earnings
Nov 14, 2022EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding65,089,043
10 Day Avg. Volume374
30 Day Avg. VolumeN/A
Standard Deviation13.04
R-Squared0.04
Alpha1.56
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.05
Price to Cash Flow (P/CF)0.10
P/FCF Ratio0.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.08
Enterprise Value/Gross Profit0.08
Enterprise Value/Ebitda-0.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Acura Pharmaceuticals News
PremiumCompany Announcements
Acura Pharmaceuticals Announces Executive Leadership Transition
PremiumCompany Announcements
Acura Pharmaceuticals Secures Loan, Faces Bankruptcy RiskOwnership Overview
6.52% Insiders
<0.01% Other Institutional Investors
93.48% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ACUR FAQ
What was Acura Pharmaceuticals’s price range in the past 12 months?
Acura Pharmaceuticals lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is Acura Pharmaceuticals’s market cap?
Currently, no data Available
When is Acura Pharmaceuticals’s upcoming earnings report date?
Acura Pharmaceuticals’s upcoming earnings report date is Nov 14, 2022 which is 744 days ago.
How were Acura Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Acura Pharmaceuticals overvalued?
According to Wall Street analysts Acura Pharmaceuticals’s price is currently Overvalued.
Does Acura Pharmaceuticals pay dividends?
Acura Pharmaceuticals does not currently pay dividends.
What is Acura Pharmaceuticals’s EPS estimate?
Acura Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acura Pharmaceuticals have?
Acura Pharmaceuticals has 66,001,785 shares outstanding.
What happened to Acura Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Acura Pharmaceuticals?
Currently, no hedge funds are holding shares in ACUR
---
Company Description
Acura Pharmaceuticals
Acura Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. Its technology platforms include AVERSION, IMPEDE, and LIMITX. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.
---
---